Navigation Links
Brain behind the Brawn: Vital Molecule in the Brain Controls Appetite

Combating obesity is one of the greatest challenges facing researchers today, and recent research holds promise for being a vital breakthrough to contain a growing epidemic.// The World Health Organization has estimated that there are a billion people in the world tackling overweight problems, of them nearly 300 million are obese.

Scientists have narrowed their sights on a new molecule that works on the source of the problem – appetite, the main reason for over weight and obesity. This molecule in the brain is capable of making a person feel full, and satisfied, which is what the world needs to set the obesity record straight.

Masatomo Mori and colleagues at Gunma University in Maebashi, Japan, have identified a key protein called nesfatin-1 which is present in the hypothalamus of rat brains. The hypothalamus is a region of the brain that regulates appetite and temperature. The effects of this molecule were observed on rats; when the molecule was injected into the brains of rats, a feeling of fullness is created , which results in the rats eating much less. This also caused the animals to lose weight.

It was observed that when the investigators injected nesfatin-1 directly into the brains of rats, the animals started eating less. When the protein was injected into their bodies without a break, for 10 days through a drip, the animals were found to lose weight.

To recheck the benefits of this molecule, antibodies blocking the action of nesfatin-1 were injected into the brains of healthy rats. The animals showed an increase in appetite that reflected in them gaining weight within 6 days.

"Nesfatin-1 might be a useful target for the development of drugs to treat obese people," the researchers say. The researchers are planning to conduct human trials that could also lead to the development of a version of the drug that can be normally injected into the body, yet assimilated in the brain to produce the desired
'"/>




Page: 1 2

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. “Brain fingerprinting”- The new lie detectr
4. Nasal Spray Could Take Drugs Direct to Brain.
5. Virus Combats Brain Tumour
6. Nasal Spray Could Take Drugs Directly to Brain
7. Control of anger disorder connected to Brain Dysfunction
8. High Levels of Protein Linked to Brain Shrinkage
9. Brain damage affects artistic skill
10. Brain cells protected by new compounds
11. Brain changes observed in people with sleep apnoea
Post Your Comments:
(Date:7/25/2008)...nship Based on Significant Improvements in Members...cor, Inc., a leader in health,care quality managem...y,announced it has entered into a long-term agreem...lmark,s Collaboration on Quality(SM) Incent and,Re...tween Wellmark and,primary care clinicians to prom...
(Date:7/25/2008)...if., July 25 /PRNewswire/ -- AutoGenomics, Inc. to...tement on Form S-1 with the,Securities and Exchang...ic,offering of shares of its common stock. The num...f which are expected to be offered by,AutoGenomics... not yet been,determined., J.P. Morgan Securities...
(Date:7/25/2008)... Whether you are an Olympian, Professional...are Five Things You Need to Know about Hydration t...e and Sports Center , Mar...ca,s premier athletes are heading to Beijing follo...acrifice in the hopes of capturing an Olympic meda...
(Date:7/24/2008)... Hoag to lease hospital facility on Sand C...ach, CA (Vocus) July 24, 2008 -- Hoag Memorial Hos...CP, Inc. (NYSE: HCP), a Real Estate Investment Tru...75-bed hospital facility on Sand Canyon Avenue nea...cility is currently operated by Tenet Healthcare C...
Breaking Medicine News(10 mins):Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
...eport published online today in the Annals of Onco...rmone treatments such as tamoxifen would prefer to...ons //were thought o significantly curb the occurr...urveyed nearly 200 breast cancer patients and aske...
...arterial calcifications (BACs) are common findings...media layer of the peripheral arterioles and this ...clerosis or medial arterial calcification. Many gr... diabetes and cardiovascular risk, but there are f...
...of researchers at Fox Chase Cancer Center in Phila...of prostate cancer may not turn up to seek fresh t...ted on the behalf of the Radiation Therapy Oncolog...rican Society for Therapeutic Radiation and Oncolo...
...US one of the top organ transplant hospitals in Ca... allegations a Saudi national improperly received ...atients.// The Los Angeles Times reported that of...also discovered that, following the transplant, so...
Other Medicine News:Health News:Association Of Breast Arterial Calcifications With Diabetes And Hypertension 2
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Medic...g solutions for more than 20 years, has entered,th...hnology to measure,regional oxygen saturation. Tod...s the continuous monitoring of the regional blood ...arly testing data and outcomes from an ongoing cli...
(Date:7/22/2008)... Study Demonstrates Feasibility and Efficacy of Tr...ary Liver Cancer, SAN FRANCISCO, and YONGIN-SI, S... (San Francisco, CA and Ottawa, Ontario), and its ...today that novel findings from,a Phase I clinical ...monstrated that the product was well-tolerated and...
(Date:7/22/2008)... CEO Geoffrey Allan Will Stress the Importance to ...iologics Approval Pathway, RICHMOND, Va., July 22... INSM) a developer of follow-on biologics and biop...n, Ph.D., CEO of Insmed, will present at a,Congres...uss the,significant need for establishing an appro...
(Date:7/22/2008)...st Developed and Validated by Columbia University ..., Proprietary MicroRNA Technology, The Test Diff...ll Lung Cancer (NSCLC), Classifying Squamous-Cell...96 Percent and Specificity of 90 Percent,This is t...NAs, Sensitivity as Biomarkers for Accura...
Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 1David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 2David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 3David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 4Millennium Ships and Records the First 24200 000 of Revenue Generated From the Five Year 2420 000 000 Exclusive Purchase Order 2095 1Millennium Ships and Records the First 24200 000 of Revenue Generated From the Five Year 2420 000 000 Exclusive Purchase Order 2095 2Millennium Ships and Records the First 24200 000 of Revenue Generated From the Five Year 2420 000 000 Exclusive Purchase Order 2095 3PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 1PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 2PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 3PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 4PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 5PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 6PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 7PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 8PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 9Diabetes Linked to Blood Vessel Inflammation 7756 1Diabetes Linked to Blood Vessel Inflammation 7756 2
...lia--(BUSINESS WIRE)--Jul 5, 2007 - Australian,bio... the,completion of apricitabine,s controlled, doub...k segment of its Phase IIb trial.,Patients have no...ial (weeks 24 to 48) and will continue to receive ...ily treatment regime.,The Company expects to relea...
...xas--(BUSINESS WIRE)--Jul 5, 2007 - Repros,Therape... article,has been published in the July 1, 2007 is... a new approach to the treatment of,breast cancer ...rom,a study conducted in an accepted in vivo rat m...collaboration with scientists,from the University ...
Other Medicine Technology:Avexa's Apricitabine Clinical Trial Update 2Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 2Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 3Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 4
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: